HIMS vs. LLY

Last updated Apr 1, 2026

Compare and contrast key facts about Hims & Hers Health, Inc. (HIMS) and Eli Lilly and Company (LLY).

Performance

HIMS vs. LLY - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Hims & Hers Health, Inc. (HIMS) and Eli Lilly and Company (LLY). The values are adjusted to include any dividend payments, if applicable.

HIMS vs. LLY - Yearly Performance Comparison

	2026 (YTD)	2025	2024	2023	2022	2021	2020	2019
HIMS Hims & Hers Health, Inc.	-36.06%	34.28%	171.69%	38.85%	-2.14%	-55.14%	47.47%	1.02%
LLY Eli Lilly and Company	-14.27%	40.25%	33.30%	60.91%	34.26%	66.08%	31.04%	19.20%

Fundamentals

Market Cap HIMS : $5.15B LLY : $825.96B
EPS HIMS : $0.51 LLY : $22.96
PE Ratio HIMS : 40.62 LLY : 40.06
PS Ratio HIMS : 2.22 LLY : 12.68
PB Ratio HIMS : 9.52 LLY : 31.13
Total Revenue (TTM) HIMS : $2.35B LLY : $65.18B
Gross Profit (TTM) HIMS : $1.73B LLY : $54.62B
EBITDA (TTM) HIMS : $142.44M LLY : $27.94B

Returns By Period

In the year-to-date period, HIMS achieves a -36.06% return, which is significantly lower than LLY's -14.27% return.

HIMS

• 1D: 10.54%
• 1M: 42.98%
• YTD: -36.06%
• 6M: -63.40%
• 1Y: -29.75%
• 3Y*: 27.91%
• 5Y*: 8.83%
• 10Y*: —

LLY

• 1D: 3.74%
• 1M: -12.57%
• YTD: -14.27%
• 6M: 20.93%
• 1Y: 12.19%
• 3Y*: 39.90%
• 5Y*: 39.16%
• 10Y*: 30.92%

*Multi-year figures are annualized to reflect compound growth (CAGR)

Return for Risk

HIMS vs. LLY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HIMS

HIMS Risk / Return Rank: 33
HIMS Sharpe Ratio Rank: 29
HIMS Sortino Ratio Rank: 36
HIMS Omega Ratio Rank: 36
HIMS Calmar Ratio Rank: 31
HIMS Martin Ratio Rank: 31

LLY

LLY Risk / Return Rank: 51
LLY Sharpe Ratio Rank: 53
LLY Sortino Ratio Rank: 48
LLY Omega Ratio Rank: 49
LLY Calmar Ratio Rank: 53
LLY Martin Ratio Rank: 54

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HIMS vs. LLY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Hims & Hers Health, Inc. (HIMS) and Eli Lilly and Company (LLY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

	HIMS	LLY	Difference
Sharpe ratio Return per unit of total volatility	-0.29	0.29	-0.58
Sortino ratio Return per unit of downside risk	0.24	0.69	-0.45
Omega ratio Gain probability vs. loss probability	1.03	1.10	-0.07
Calmar ratio Return relative to maximum drawdown	-0.37	0.42	-0.79
Martin ratio Return relative to average drawdown	-0.73	1.02	-1.75
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

HIMS vs. LLY - Sharpe Ratio Comparison

The current HIMS Sharpe Ratio is -0.29, which is lower than the LLY Sharpe Ratio of 0.29. The chart below compares the historical Sharpe Ratios of HIMS and LLY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Sharpe Ratios by Period

	HIMS	LLY	Difference
Sharpe Ratio (1Y) Calculated over the trailing 1-year period	-0.29	0.29	-0.58
Sharpe Ratio (5Y) Calculated over the trailing 5-year period	0.11	1.23	-1.12
Sharpe Ratio (10Y) Calculated over the trailing 10-year period	—	1.04	—
Sharpe Ratio (All Time) Calculated using the full available price history	0.16	0.56	-0.40

Correlation

The correlation between HIMS and LLY is 0.13, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

HIMS vs. LLY - Dividend Comparison

HIMS has not paid dividends to shareholders, while LLY's dividend yield for the trailing twelve months is around 0.68%.

	TTM	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015
HIMS Hims & Hers Health, Inc.	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%
LLY Eli Lilly and Company	0.68%	0.56%	0.67%	0.78%	1.07%	1.23%	1.75%	1.96%	1.94%	2.46%	2.77%	2.37%

Drawdowns

HIMS vs. LLY - Drawdown Comparison

The maximum HIMS drawdown since its inception was -87.29%, which is greater than LLY's maximum drawdown of -68.24%. Use the drawdown chart below to compare losses from any high point for HIMS and LLY.

Drawdown Indicators

	HIMS	LLY	Difference
Max Drawdown Largest peak-to-trough decline	-87.29%	-68.24%	-19.05%
Max Drawdown (1Y) Largest decline over 1 year	-78.06%	-30.26%	-47.80%
Max Drawdown (5Y) Largest decline over 5 years	-79.74%	-34.48%	-45.26%
Max Drawdown (10Y) Largest decline over 10 years	—	-34.48%	—
Current Drawdown Current decline from peak	-69.80%	-17.00%	-52.80%
Average Drawdown Average peak-to-trough decline	-42.65%	-19.25%	-23.40%
Ulcer Index Depth and duration of drawdowns from previous peaks	39.63%	12.39%	+27.24%

Volatility

HIMS vs. LLY - Volatility Comparison

Hims & Hers Health, Inc. (HIMS) has a higher volatility of 43.03% compared to Eli Lilly and Company (LLY) at 9.04%. This indicates that HIMS's price experiences larger fluctuations and is considered to be riskier than LLY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Volatility by Period

	HIMS	LLY	Difference
Volatility (1M) Calculated over the trailing 1-month period	43.03%	9.04%	+33.99%
Volatility (6M) Calculated over the trailing 6-month period	64.90%	26.21%	+38.69%
Volatility (1Y) Calculated over the trailing 1-year period	101.79%	42.44%	+59.35%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	83.68%	32.14%	+51.54%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	76.87%	29.80%	+47.07%

Financials

HIMS vs. LLY - Profitability Comparison

The chart below illustrates the profitability comparison between Hims & Hers Health, Inc. and Eli Lilly and Company over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

HIMS - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Hims & Hers Health, Inc. reported a gross profit of 444.44M and revenue of 617.82M. Therefore, the gross margin over that period was 71.9%.

LLY - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Apr 2026, Eli Lilly and Company reported a gross profit of 16.41B and revenue of 19.29B. Therefore, the gross margin over that period was 85.1%.

HIMS - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Hims & Hers Health, Inc. reported an operating income of 9.19M and revenue of 617.82M, resulting in an operating margin of 1.5%.

LLY - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Apr 2026, Eli Lilly and Company reported an operating income of 8.78B and revenue of 19.29B, resulting in an operating margin of 45.5%.

HIMS - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Hims & Hers Health, Inc. reported a net income of 20.60M and revenue of 617.82M, resulting in a net margin of 3.3%.

LLY - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Apr 2026, Eli Lilly and Company reported a net income of 6.64B and revenue of 19.29B, resulting in a net margin of 34.4%.